Literature DB >> 10799589

Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.

A Ono1, D Demirov, E O Freed.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Gag precursor, Pr55(Gag), is necessary and sufficient for the assembly and release of viruslike particles. Binding of Gag to membrane and Gag multimerization are both essential steps in virus assembly, yet the domains responsible for these events have not been fully defined. In addition, the relationship between membrane binding and Gag-Gag interaction remains to be elucidated. To investigate these issues, we analyzed, in vivo, the membrane-binding and assembly properties of a series of C-terminally truncated Gag mutants. Pr55(Gag) was truncated at the C terminus of matrix (MAstop), between the N- and C-terminal domains of capsid (CA146stop), at the C terminus of capsid (p41stop), at the C terminus of p2 (p43stop), and after the N-terminal 35 amino acids of nucleocapsid (NC35stop). The ability of these truncated Gag molecules to assemble and release viruslike particles and their capacity to copackage into particles when coexpressed with full-length Gag were determined. We demonstrate that the amount of truncated Gag incorporated into particles is incrementally increased by extension from CA146 to NC35, suggesting that multiple sites in this region are involved in Gag multimerization. Using membrane flotation centrifugation, we observe that MA shows significantly reduced membrane binding relative to full-length Gag but that CA146 displays steady-state membrane-binding properties comparable to those of Pr55(Gag). The finding that the CA146 mutant, which contains only matrix and the N-terminal domain of capsid, exhibits levels of steady-state membrane binding equivalent to those of full-length Gag indicates that strong Gag-Gag interaction domains are not required for the efficient binding of HIV-1 Gag to membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799589      PMCID: PMC110867          DOI: 10.1128/jvi.74.11.5142-5150.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.

Authors:  R E Kiernan; A Ono; G Englund; E O Freed
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles.

Authors:  C T Wang; J Stegeman-Olsen; Y Zhang; E Barklis
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

3.  Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.

Authors:  E O Freed; J M Orenstein; A J Buckler-White; M A Martin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.

Authors:  E J Platt; O K Haffar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.

Authors:  C T Wang; E Barklis
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.

Authors:  C T Wang; Y Zhang; J McDermott; E Barklis
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins.

Authors:  R M Peitzsch; S McLaughlin
Journal:  Biochemistry       Date:  1993-10-05       Impact factor: 3.162

8.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.

Authors:  R P Bennett; T D Nelle; J W Wills
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.

Authors:  W Zhou; L J Parent; J W Wills; M D Resh
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  75 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Interaction of Moloney murine leukemia virus matrix protein with IQGAP.

Authors:  Juliana Leung; Andrew Yueh; Frank S K Appah; Bing Yuan; Kenia de los Santos; Stephen P Goff
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

4.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

5.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.

Authors:  Robert A Dick; Marilia Barros; Danni Jin; Mathias Lösche; Volker M Vogt
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

7.  Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein.

Authors:  Joseph F Nabhan; Ruoxi Hu; Raymond S Oh; Stanley N Cohen; Quan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

8.  Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.

Authors:  Claudia S López; Seyram M Tsagli; Rachel Sloan; Jacob Eccles; Eric Barklis
Journal:  Virology       Date:  2013-09-21       Impact factor: 3.616

9.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Authors:  Daniel Melamed; Michal Mark-Danieli; Michal Kenan-Eichler; Osnat Kraus; Asher Castiel; Nihay Laham; Tal Pupko; Fabian Glaser; Nir Ben-Tal; Eran Bacharach
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.